Corrigan Mark
- SEC CIK
- 0001250661
In the past year, 1 open-market sale filing worth $217.3K and no purchases.
Current role at each company
- WVE Wave Life Sciences, Inc.Directoras of Dec 10, 2025
- TRVN Trevena IncDirectoras of Jun 14, 2024
- Nabriva Therapeutics plcDirectoras of Aug 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $217.3K
- 1 filing
- Net
- −$217.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Corrigan Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WVE Wave Life Sciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 (view filing) | Dec 8 | 2 days | Corrigan MarkDirector | SSale | −16.1K | $13.49 | −$217.3K | −35.9%28.8K after | 2 lots10b5-1 |
Nabriva Therapeutics plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 (view filing)6:19 PM ET | Aug 2 | 2 days | Corrigan MarkDirector | SSale | −10.3K | $0.19 | −$1.96K | −58.8%7.20K after |